Lithuanian AI Platform Secures €30M to Tackle Enterprise Adoption Hurdles and Shadow AI Risks

Major Funding for European AI Infrastructure

Lithuanian startup nexos.ai has reportedly secured €30 million in Series A funding to accelerate enterprise AI adoption while addressing what sources describe as the growing “Shadow AI” challenge within organizations. According to reports, the Vilnius-based company aims to remove critical blockers preventing large-scale AI implementation across enterprises.

Major Funding for European AI Infrastructure
Tackling the Shadow AI Epidemic
Comprehensive Platform Approach
Experienced Leadership Team
Regional Context and Market Position
Future Expansion Plans

The funding round was co-led by former Sequoia Capital partner Matt Miller’s debut fund Evantic Capital and existing investor Index Ventures, with participation from previous investors Creandum, Dig Ventures, and notable angel investors. Analysts suggest this substantial investment signals growing confidence in platforms that enable secure, compliant AI adoption across large organizations.

Tackling the Shadow AI Epidemic

nexos.ai CEO and Co-founder Tomas Okmanas highlighted the urgency of addressing unauthorized AI usage within companies. “While security teams focus on traditional cyber threats like ransomware, their own employees are carrying out the biggest data leak in corporate history right under their noses,” he stated in the company announcement.

Industry observers indicate that what’s being termed “Shadow AI”—the unsanctioned use of AI tools by employees—creates significant security vulnerabilities and compliance risks. The report states that companies typically follow a predictable pattern: initial AI excitement leads to purchasing multiple tools that don’t integrate, resulting in exploding costs and eventual abandonment of most solutions.

Comprehensive Platform Approach

According to the company‘s description, nexos.ai provides an all-in-one platform combining an AI Workspace for employees with an AI Gateway for developers. The unified interface reportedly supports over 200 AI models while maintaining centralized security, cost management, and compliance oversight.

The platform’s AI Workspace enables teams to chat with multiple large language models in one interface while maintaining security through customizable guardrails and role-based access controls. Sources indicate the system prevents data leaks through detailed logging and trace visibility while allowing teams to compare models side-by-side and collaborate on AI projects.

For developers, the AI Gateway provides plug-and-play API access to orchestrate all models through one endpoint, intelligent caching to reduce costs, and Retrieval-Augmented Generation capabilities to ground responses in company documents.

Experienced Leadership Team

The company was founded in 2024 by the creators of cybersecurity unicorn Nord Security, with Okmanas and Co-founder Eimantas Sabaliauskas having bootstrapped Nord Security to global market leadership over 12 years. Matt Miller of Evantic Capital described Okmanas as “a force of nature in the European tech scene” in the funding announcement.

Miller, who previously helped scale Confluent and dbt Labs at Sequoia Capital, added that “nexos.ai addresses the fundamental infrastructure gap preventing enterprises from capturing AI’s value while maintaining security control.”

Regional Context and Market Position

The funding occurs alongside other significant European AI investments, including the UK-based Synthesized (€17 million Series A), Denmark’s Light (€25 million Series A), Sweden’s EvoluteIQ (€44 million growth round), and the UK’s Conduct (€11.2 million Seed round). While none are Lithuanian, Sweden’s EvoluteIQ stands out as a Nordic neighbour pursuing similar enterprise-AI goals.

Hannah Seal, Partner at Index Ventures, commented that “nexos.ai has rapidly evolved from concept to enterprise-ready platform, driven by urgent market demand to deploy AI securely and remove barriers to adoption. As enterprises move from running pilot projects to full-scale deployment, many are turning to nexos.ai to help them deliver clear ROI.”

Future Expansion Plans

The €30 million investment will reportedly accelerate platform development, including advanced routing algorithms, private model deployment capabilities, and expansion across Europe and North America. The company also plans to launch educational partnerships to address enterprise AI skills gaps.

Okmanas emphasized the time-sensitive nature of the challenge, suggesting that “enterprises have between 12-24 months to architect proper AI infrastructure or face existential competitive disadvantage.” According to analysts, this funding positions nexos.ai to help organizations overcome critical barriers during this crucial adoption window.

References & Further Reading

This article draws from multiple authoritative sources. For more information, please consult:

This article aggregates information from publicly available sources. All trademarks and copyrights belong to their respective owners.

Note: Featured image is for illustrative purposes only and does not represent any specific product, service, or entity mentioned in this article.

The medical AI sector continues to attract significant investment as OpenEvidence reportedly secures $200 million in new funding. The platform, which doctors compare to a medical version of ChatGPT, has seen rapid adoption since its 2022 launch according to industry reports.

Medical AI Platform Achieves Major Funding Milestone

OpenEvidence, an artificial intelligence platform that healthcare professionals have described as a specialized ChatGPT for medical applications, has reportedly secured $200 million in new funding at a $6 billion valuation, according to The New York Times. This substantial investment comes just three months after the company raised $210 million at a $3.5 billion valuation, indicating continued strong investor confidence in specialized AI applications for specific industries.